• Nenhum resultado encontrado

The Current State of Neoadjuvant Chemotherapy for Muscle-Invasive Bladder Cancer

N/A
N/A
Protected

Academic year: 2017

Share "The Current State of Neoadjuvant Chemotherapy for Muscle-Invasive Bladder Cancer"

Copied!
6
0
0

Texto

Loading

Imagem

Table 1: Randomised Phase III trials with regard to neoadjuvant chemotherapy for the treatment of   muscle-invasive bladder cancer.

Referências

Documentos relacionados

Conclusions: Selected patients with muscle-invasive bladder cancers may survive after transurethral resection and neoadjuvant chemotherapy, and tumor features can identify

Conclusions: Selected patients with muscle-invasive bladder cancers may survive after transurethral resection and neoadjuvant chemotherapy, and tumor features can identify

The EORTC tables overestimate the risk of recurrence and progression in patients with non-muscle- invasive bladder cancer treated with bacillus Calmette-Guérin: external validation

In the current study, the authors sought to character- ize practice patterns in patients with high-grade non-muscle-invasive bladder cancer in relation to established

However, a recent study has shown that for the high risk patients with non-muscle invasive bladder cancer (NMIBC) a single instillation of perioperative intravesical

Figure 1 b - Kaplan Meier plots assessing cancer-specific survival in patients with muscle invasive urothelial carcinoma of the bladder (MIBC) treated with radical cystectomy (RC)

Adjuvant systemic chemotherapy in the treatment of patients with invasive transitional cell carcinoma of the upper urinary tract.. Babjuk M, Burger M, Zigeuner R, Shariat SF,

The aim of this study is to assess the awareness of non-muscle invasive bladder cancer (NMIBC) patients regarding the importance of smoking cessation, determine their ac- cess